Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Non Small Cell Lung Cancer Squamous (NSCLC-Sq)”

10 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 10 of 10 results

Early research (Phase 1)Looking for participantsNCT07638891
What this trial is testing

HDM2020 in Patients With Advanced Sq-NSCLC

Who this might be right for
Squamous Non-small Cell Lung Cancer(NSCLC)
Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd. 150
Testing effectiveness (Phase 2)Study completedNCT02409368
What this trial is testing

An Open-Label, Multicenter Clinical Trial With Nivolumab (BMS-936558) Monotherapy in Subjects With Advanced or Metastatic Squamous Cell (Sq) Non-Small Cell Lung Cancer (NSCLC) Who Have Received at Least One Prior Systemic Regimen for the Treatment of Stage IIIb/IV SqNSCLC

Who this might be right for
Non-Small Cell Lung Cancer
Bristol-Myers Squibb 812
Large-scale testing (Phase 3)Not Yet RecruitingNCT07360132
What this trial is testing

Phase III Clinical Study of HB0025 Combined With Chemotherapy Versus Pembrolizumab Combined With Chemotherapy for the First-Line Treatment of Advanced Squamous Non-Small Cell Lung Cancer

Who this might be right for
Squamous Non-small Cell Lung Cancer
Shanghai Huaota Biopharmaceutical Co., Ltd. 480
Not applicableNo Longer AvailableNCT02475382
What this trial is testing

Expanded Access Program With Nivolumab Therapy for Treatment of Advanced/Metastatic SqNSCLC or Non-SqNSCLC After One Prior Systemic Regimen

Who this might be right for
Squamous Non-Small Cell Lung CancerNon-squamous Non-Small Cell Lung Cancer
Bristol-Myers Squibb
Not applicableStudy completedNCT03132493
What this trial is testing

Nivolumab in the Real World: Analysis of the Expanded Use in Spanish Patient

Who this might be right for
Non Small Cell Lung Cancer
Spanish Lung Cancer Group 676
Early research (Phase 1)Ended earlyNCT06376253
What this trial is testing

A Phase I Study of [177Lu]Lu-EVS459 in Patients With Ovarian and Lung Cancers

Who this might be right for
Ovarian CancerLung Cancer
Novartis Pharmaceuticals 4
Testing effectiveness (Phase 2)UnknownNCT04396457
What this trial is testing

Pembrolizumab Plus Pemetrexed for Elderly Patients With Non-Sq NSCLC With PD-L1 < 50%: CJLSG1901

Who this might be right for
Non-squamous Non-small-cell Lung CancerCancer, Lung
National Hospital Organization Nagoya Medical Center 50
Early research (Phase 1)Study completedNCT03811652
What this trial is testing

A Multiple Ascending Dose Study of MEDI7247 in Advanced or Metastatic Solid Tumors

Who this might be right for
Non Small Cell Lung Cancer Squamous (NSCLC-Sq)Head and Neck Squamous Cell Carcinoma (HNSCC)Small Cell Lung Cancer (SCLC)+3 more
MedImmune LLC 8
Testing effectiveness (Phase 2)UnknownNCT05243355
What this trial is testing

Envafolimab Combined With Chemotherapy and Recombinant Human Endostatin in the First-line Treatment of Sq-NSCLC

Who this might be right for
Squamous Non-small Cell Lung Cancer
Qilu Hospital of Shandong University 46
Early research (Phase 1)Not Yet RecruitingNCT07614646
What this trial is testing

Evaluate the Safety, Tolerability, and Preliminary Efficacy of EVM14 in Combination With Ivonescimab in Sq-NSCLC Patients

Who this might be right for
Squamous Non-Small Cell Lung Cancer sqNSCLC
Everest Medicines (Beijing) Co., Ltd. 13